Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.

Autor: Feldman PR; Arbor Life Labs, Toronto, ON, Canada.; Norwich Medical School, University of East Anglia, Norwich, United Kingdom., Gentile P; Surgical Science Department, University of Rome Tor Vergata, Rome, Italy., Piwko C; CHP Pharma Inc., Thornhill, ON, Canada., Motswaledi HM; Department of Dermatology, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Gorun S; Faculty of Epidemiology and Biostatistics, Western University, London, ON, Canada.; School or Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom., Pesachov J; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Markel M; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Silver MI; Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada., Brenkel M; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Feldman OJ; Arbor Life Labs, Toronto, ON, Canada.; Faculty of Science, Wilfrid Laurier University, Waterloo, ON, Canada., Kamen CL; Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Uleryk E; Uleryk Consulting, Mississauga, ON, Canada., Guevara-Aguirre J; College of Medicine, Universidad San Francisco De Quito (USFQ), Quito, Ecuador.; Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.; Institute of Endocrinology, Metabolism, and Reproduction (IEMYR), Quito, Ecuador.; College of Medicine, University of Florida, Gainesville, FL, United States., Fiebig KM; Arbor Life Labs, Toronto, ON, Canada.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2023 Jan 23; Vol. 9, pp. 998623. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2022).

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.

Autor: Feldman PR; Arbor Life Labs, Toronto, Ontario, Canada., Fiebig KM; Arbor Life Labs, Toronto, Ontario, Canada., Piwko C; CHP Pharma Inc, Thornhill, Ontario, Canada., Mints BM; B&B International, Vilnius, Lithuania., Brown D; Valent Technologies, Menlo Park, California, USA., Cahan DJ; Arbor Life Labs, Toronto, Ontario, Canada., Guevara-Aguirre J; Universidad San Francisco de Quito (USFQ), Quito, Ecuador.; Institute of Endocrinology, Metabolism, and Reproduction (IEMYR), Quito, Ecuador.; Maastricht University, Maastricht, The Netherlands.; College of Medicine, University of Florida, Gainesville, Florida, USA.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2021 Jun 24; Vol. 37, pp. 100978. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).

Comparison of two proxies for the preconception weight using data from a pre-pregnancy cohort in Benin: Weight measured in the first trimester of pregnancy vs estimated by Thomas' formula.

Autor: Yovo, Emmanuel^1,2 (AUTHOR) emkoffiyovo@gmail.com, Accrombessi, Manfred^1,3 (AUTHOR), Briand, Valérie^4,5 (AUTHOR), Agbota, Gino^1,6 (AUTHOR), Hounkonnou, Cornelia¹ (AUTHOR), Alao, Jules⁷ (AUTHOR), Zeitlin, Jennifer⁸ (AUTHOR), Traissac, Pierre² (AUTHOR), Martin-Prevel, Yves² (AUTHOR)

Publikováno v: PLoS ONE. 11/4/2024, Vol. 19 Issue 11, p1-14. 14p.

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

Autor: Einarson, T.R. Geitona, M. Chaidemenos, A. Karpouza, V. Mougiakos, T. Paterakis, P. Ploumpidis, D. Potamitis-Komis, D. Zilbershtein, R. Vicente, C. Piwko, C. Kakkavas, P. Paparouni, K. Jensen, R.C.D. Hemels, M.E.H.

Background: Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::1ccb37b4796a0f5cd69f4e090abc7113
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111081

Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.

Autor: Jin, Su-Eon¹ (AUTHOR) sjin@epibiotech.com, Sung, Jong-Hyuk¹ (AUTHOR) sjin@epibiotech.com

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7612. 24p.